Joshua A. Kazam - Jan 12, 2022 Form 4 Insider Report for Allogene Therapeutics, Inc. (ALLO)

Role
Director
Signature
/s/ Veer Bhavnagri, Attorney-in-Fact
Stock symbol
ALLO
Transactions as of
Jan 12, 2022
Transactions value $
$189,000
Form type
4
Date filed
1/14/2022, 01:13 PM
Previous filing
Jan 6, 2022
Next filing
Mar 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ALLO Common Stock Purchase $189K +15K +6.15% $12.60 259K Jan 12, 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.